SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-002518 to CASTLE BIOSCIENCES INC (CSTL) (CIK 0001447362) (CSTL)

CASTLE BIOSCIENCES INC (CSTL) (CIK 0001447362)
Date: March 7, 2024 · CIK: 0001447362 · Accession: 0000000000-24-002518

AI Filing Summary & Sentiment

File numbers found in text: 333-277470

Date
March 7, 2024
Author
Not clearly detected
Form
UPLOAD
Company
CASTLE BIOSCIENCES INC (CSTL) (CIK 0001447362)

Letter

United States securities and exchange commission logo March 7, 2024 Derek Maetzold President and Chief Executive Officer Castle Biosciences Inc. 505 S. Friendswood Drive, Suite 401 Friendswood, Texas 77546 Re:Castle Biosciences Inc. Registration Statement on Form S-3 Filed February 28, 2024 File No. 333-277470 Dear Derek Maetzold: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Robert Augustin at 202-551-8483 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Thomas Coll

Show Raw Text
United States securities and exchange commission logo
March 7, 2024
Derek Maetzold
President and Chief Executive Officer
Castle Biosciences Inc.
505 S. Friendswood Drive, Suite 401
Friendswood, Texas 77546
Re:Castle Biosciences Inc.
Registration Statement on Form S-3
Filed February 28, 2024
File No. 333-277470
Dear Derek Maetzold:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Robert Augustin at 202-551-8483 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Thomas Coll